Dr. Jain is a member of the Division of Anatomic Pathology and Thoracic Pathology Center of Excellence.
Her primary areas of clinical expertise includes thoracic pathology, with a focus on lung cancer and thymic neoplasms, as well as cytopathology and sinonasal malignancies.
Dr Jain is a member of the International Association for Study of Lung Cancer (IASLC) and serves on the Pathology and Education committees. She is Editorial Board member of 2021 World Health Organization (WHO) classification of Thoracic Tumors and 2022 WHO-IAC International System for Reporting Lung Cytopathology. She is a member of the International Collaboration on Cancer Reporting (ICCR) Thymic Epithelial Tumors dataset authoring committee. She has contributed chapters to several WHO classification volumes including Thoracic Tumors, Head Neck tumors, Endocrine and Neuroendocrine tumors, and the WHO Cytopathology Classification system for Lung, Soft tissues, and Head Neck.
Dr. Jain has authored and coauthored over 370 peer-reviewed articles and multiple book chapters. She has edited two books: Atlas of Thymic Pathology and Atlas of Sinonasal Tract Pathology. Her current primary research focuses on the application of artificial intelligence for biomarker prediction, investigation of the microbiome’s role, and the advancement of sequencing technologies in both tissue and liquid biopsies for lung cancer.
She is a recipient of numerous distinguished national and international scientific awards including IASLC Mary J Matthews Pathology/Translational research award.